癌症中的短粘素类型O-甘氨酸:在分析障碍中生物标志物和治疗潜力
Henrique Sousa1,2, Inês A B Ribeiro1,2, Marta Falcão1,2,3
1UCIBIO - Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, Caparica, Portugal.
Glycobiology
|November 20, 2025
概括
像Tn抗原和sialyl-Tn (STn) 这样的截断的粘素类型O-甘氨酸与癌症进展和预后不佳有关. 分析技术的进步为它们作为癌症生物标志物和治疗点的使用提供了新的机会.
科学领域:
- 生物化学 生物化学
- 葡萄糖生物学 葡萄糖生物学
- 癌症生物学 癌症生物学
背景情况:
- 类型O-甘氨酸是关键的蛋白质修饰,参与细胞信号传递和免疫反应.
- 癌症中的O-甘氨酸生物合成中断导致Tn抗原和基-Tn (STn) 等异常结构,促进恶性瘤.
- 这些截断的甘氨酸与预后不佳有关,是潜在的生物标志物和治疗点.
研究的目的:
- 审查生物合成起源,生物作用和癌症中切断的O-糖的临床意义.
- 讨论阻碍这些糖形式的临床翻译的分析挑战.
- 突出新兴技术和未来的方向,以整合截断的O-glycans到精密瘤学.
主要方法:
- 关于O-糖甘生物合成,癌症生物学和分析技术的当前文献的综述.
- 讨论糖蛋白组学,糖组学和抗体工程的进展.
- 对临床应用的挑战和机会进行批判性分析.
主要成果:
- 截断的O-甘氨酸 (Tn抗原,STn) 在癌症中普遍存在,导致恶性瘤的特征.
- 这些异常的甘氨酸作为潜在的诊断和预后生物标志物.
- 新兴技术正在改善与癌症相关的葡萄糖形式的表征和检测.
结论:
- 截断的O-甘氨酸在癌症的发展和进展中起着重要作用.
- 克服分析挑战是利用这些甘氨酸作为生物标志物和治疗点的关键.
- 未来的方向包括整合先进的糖化学和抗体工程,用于精密瘤学.
相关概念视频
Proteoglycans
4.6K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.6K
Oligosaccharide Assembly
3.5K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.5K


